Insiders · RZLT

RZLT insider transactions

Rezolute Inc. (RZLT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for RZLT

• 32d
  SEC Form 4 filed by Evans Daron

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 59d
  Chief Medical Officer Roberts Brian Kenneth covered exercise/tax liability with 11,439 shares, decreasing direct ownership by 4% to 296,913 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 59d
  CFO Evans Daron covered exercise/tax liability with 11,438 shares, decreasing direct ownership by 3% to 404,462 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 59d
  CEO Elam Nevan C covered exercise/tax liability with 27,618 shares, decreasing direct ownership by 4% to 613,501 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 136d
  Director Hogenhuis Wladimir bought $9,548 worth of shares (5,650 units at $1.69), increasing direct ownership by 5% to 119,675 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 136d
  Chief Medical Officer Roberts Brian Kenneth bought $47,600 worth of shares (28,000 units at $1.70), increasing direct ownership by 10% to 308,352 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 138d
  CFO Evans Daron bought $79,578 worth of shares (45,000 units at $1.77), increasing direct ownership by 11% to 415,900 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 138d
  CEO Elam Nevan C bought $50,880 worth of shares (32,000 units at $1.59), increasing direct ownership by 5% to 641,119 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 138d
  Chief Commercial Officer Karnawat Sunil Ratilal bought $19,599 worth of shares (12,100 units at $1.62), increasing direct ownership by 20% to 71,542 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 162d
  Chief Medical Officer Roberts Brian Kenneth was granted 123,000 shares, increasing direct ownership by 78% to 280,352 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 162d
  Chief Commercial Officer Karnawat Sunil Ratilal was granted 32,000 shares, increasing direct ownership by 117% to 59,442 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 162d
  CEO Elam Nevan C was granted 317,000 shares, increasing direct ownership by 109% to 609,119 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 162d
  CFO Evans Daron was granted 107,000 shares, increasing direct ownership by 40% to 375,900 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 162d
  Director Kreher Nerissa was granted 21,000 shares, increasing direct ownership by 56% to 58,576 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 162d
  Director Hogenhuis Wladimir was granted 21,000 shares, increasing direct ownership by 23% to 114,025 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 162d
  Director Harris Erik was granted 21,000 shares (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 162d
  Director Kim Young-Jin was granted 21,000 shares, increasing direct ownership by 14% to 170,950 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 162d
  Director Fauchet Philippe was granted 21,000 shares, increasing direct ownership by 61% to 55,500 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 162d
  Director Labrucherie Gil M was granted 21,000 shares, increasing direct ownership by 61% to 55,500 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 248d
  Chief Commercial Officer Karnawat Sunil Ratilal was granted 25,000 shares, increasing direct ownership by 1,024% to 27,442 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 248d
  New insider Karnawat Sunil Ratilal claimed ownership of 12,340 shares (SEC Form 3)

  3 - Rezolute, Inc. (0001509261) (Issuer)
• 310d
  Chief Medical Officer Roberts Brian Kenneth bought $10,939 worth of shares (2,500 units at $4.38), increasing direct ownership by 19% to 15,500 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 312d
  CFO Evans Daron bought $20,250 worth of shares (5,000 units at $4.05), increasing direct ownership by 2% to 268,900 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 313d
  Director Kim Young-Jin bought $3,999,999 worth of shares (1,230,769 units at $3.25) (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 313d
  Director Kreher Nerissa bought $9,997 worth of shares (3,076 units at $3.25), increasing direct ownership by 9% to 37,576 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 323d
  Director Kreher Nerissa was granted 9,000 shares, increasing direct ownership by 35% to 34,500 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 323d
  Director Labrucherie Gil M was granted 9,000 shares, increasing direct ownership by 35% to 34,500 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 323d
  Director Hogenhuis Wladimir was granted 9,000 shares, increasing direct ownership by 11% to 93,025 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 324d
  Director Kim Young-Jin was granted 9,000 shares, increasing direct ownership by 6% to 149,950 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 324d
  CFO Evans Daron was granted 26,000 shares, increasing direct ownership by 11% to 263,900 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 324d
  Director Fauchet Philippe was granted 9,000 shares, increasing direct ownership by 35% to 34,500 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 324d
  Chief Medical Officer Roberts Brian Kenneth was granted 26,000 shares, increasing direct ownership by 20% to 157,352 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 324d
  CEO Elam Nevan C was granted 68,000 shares, increasing direct ownership by 30% to 292,119 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 396d
  Director Hogenhuis Wladimir bought $19,733 worth of shares (6,758 units at $2.92), increasing direct ownership by 9% to 84,025 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 397d
  CEO Elam Nevan C bought $34,999 worth of shares (12,302 units at $2.85), increasing direct ownership by 6% to 224,119 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 400d
  CFO Evans Daron bought $57,700 worth of shares (20,000 units at $2.88), increasing direct ownership by 4% to 237,900 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 402d
  SEC Form 4 filed by Director Harris Erik

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 402d
  SEC Form 3 filed by new insider Harris Erik

  3 - Rezolute, Inc. (0001509261) (Issuer)
• 436d
  Director Hogenhuis Wladimir was granted 25,500 shares and bought $47,000 worth of shares (10,000 units at $4.70), increasing direct ownership by 85% to 77,267 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 436d
  Director Labrucherie Gil M was granted 25,500 shares (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 437d
  CFO Evans Daron was granted 77,000 shares, increasing direct ownership by 51% to 227,900 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 437d
  Director Kreher Nerissa was granted 25,500 shares (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 437d
  Director Kim Young-Jin was granted 25,500 shares and bought $5,000,000 worth of shares (1,250,000 units at $4.00), increasing direct ownership by 22% to 140,950 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 437d
  Chief Medical Officer Roberts Brian Kenneth was granted 77,000 shares, increasing direct ownership by 142% to 131,352 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 437d
  CEO Elam Nevan C was granted 204,000 shares, increasing direct ownership by 2,610% to 211,817 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 437d
  Director Fauchet Philippe was granted 25,500 shares (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 500d
  CFO Evans Daron bought $42,900 worth of shares (10,000 units at $4.29), increasing direct ownership by 7% to 150,900 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 506d
  CFO Evans Daron bought $41,400 worth of shares (9,000 units at $4.60), increasing direct ownership by 7% to 140,900 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 508d
  CFO Evans Daron bought $53,167 worth of shares (10,549 units at $5.04), increasing direct ownership by 9% to 131,900 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 585d
  Director Hogenhuis Wladimir bought $20,017 worth of shares (4,259 units at $4.70), increasing direct ownership by 11% to 41,767 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 585d
  SEC Form 4 filed by CFO Evans Daron

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 674d
  Director Hogenhuis Wladimir bought $19,982 worth of shares (4,815 units at $4.15), increasing direct ownership by 15% to 37,508 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 687d
  Chief Medical Officer Roberts Brian Kenneth bought $29,743 worth of shares (7,600 units at $3.91), increasing direct ownership by 9% to 54,352 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 687d
  CFO Evans Daron bought $161,568 worth of shares (40,000 units at $4.04) (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 701d
  Evans Daron bought $1,578 worth of shares (451 units at $3.50), increasing direct ownership by 0.37% to 121,351 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 704d
  Roberts Brian Kenneth bought $20,138 worth of shares (7,500 units at $2.69), increasing direct ownership by 18% to 50,052 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 704d
  Evans Daron bought $9,668 worth of shares (3,000 units at $3.22) (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 764d
  Roberts Brian Kenneth bought $1,275 worth of shares (500 units at $2.55) (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 774d
  Handok, Inc. bought $17,000,002 worth of shares (3,927,126 units at $4.33), increasing direct ownership by 195% to 5,942,617 units (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)
• 774d
  Evans Daron bought $33,830 worth of shares (20,000 units at $1.69) (SEC Form 4)

  4 - Rezolute, Inc. (0001509261) (Issuer)